ʻaoʻao_banner

Nā huahana

Fmoc-Lys(Boc)-OH Cas:71989-26-9

ʻO ka wehewehe pōkole:

Ka helu helu: XD91503
Cas: 71989-26-9
ʻAno Molekala: C26H32N2O6
Kaumaha Molekala: 468.54
Loaʻa: Loaʻa
Kumukuai:  
Hoʻopili mua:  
Pūʻulu Nui: Noi Manao

 


Huahana Huahana

Huahana Huahana

Helu Helu XD91503
inoa mea kūʻai Fmoc-Lys(Boc)-OH
CAS 71989-26-9
ʻAno Molekalala C26H32N2O6
Kaumaha Molecular 468.54
Nā kikoʻī mālama Ambient
Kānāwai Kūʻai Kūlike 2924299090

Huahana Huahana

Ka nana aku keʻokeʻo i ka pauka aniani melemele māmā
ʻO Assay 99% min
Lae hehee 130-135 °C (Dek.)
alpha -12 º (c=2, DMF 24 ºC)
Lae paila 570.69°C (manaʻo koʻikoʻi)
mānoanoa 1.2301 (manaʻo koʻikoʻi)
hōʻike hoʻopaʻapaʻa -12 ° (C=1, DMF)
pka 3.88±0.21(Wānana ʻia)
hana ʻōpika [α]20/D 12±1°, c = 1% ma DMF
Hiki i ka wai Hiki ke hoʻoheheʻe ʻia i ka wai.
Paʻa: Paʻa.ʻAʻole kūpono me nā mea oxidizing ikaika.

 

Hoʻohana: Hoʻohana ʻia ia e hoʻomākaukau i ka dimeric RGD peptide-paclitaxel conjugate ma ke ʻano he kumu hoʻohālike no ka lawe ʻana i ka lāʻau lapaʻau integrin.Hoʻohana ʻia ia e synthesize DOTA-conjugated multivalent cyclic-RGD peptide dendrimers no ka huli ʻana i ka maʻi maʻi a me ka hoʻohana kiʻi.

Hoʻohana: Hiki ke hoʻohana ʻia ʻo Fmoc-Lys(Boc)-OH no: ʻO ka synthesis solid-phase o nā paʻakai dihydroimidazolylbutyl dihydroimidazolylbutyl dihydroimidazol-3-ium i hoʻohui ʻia ma o ka hui ʻana me ka resin p-methylbenzhydrylamine (MBHA). Fmoc-based peptide synthesis o bis-naphthalene diimide , he threading intercalator.Synthesis o ε-Boc-ε-(3,5-bis-trifluoromethyl-benzyl)-α-Fmoc-L-Lysine e hoʻohana ʻia e like me 19F NMR ma muli o ka mea hana nānā.


  • Mua:
  • Aʻe:

  • Pani

    Fmoc-Lys(Boc)-OH Cas:71989-26-9